系统毛细血管泄漏综合征的病例报告:当有多个诱导因素存在时,问题是谁拉动触发器?
Vasileios Patriarcheas1, Eleftheria Ztriva1, Vasiliki Gougoula1
1First Propedeutic Department of Internal Medicine, American Hellenic Educational Progressive Association (AHEPA) University Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Cureus
|February 11, 2025
概括
系统毛细血管泄漏综合征 (SCLS) 是一种罕见的疾病,导致液体泄漏. 这一案例凸显了COVID-19后SCLS与骨髓增殖性瘤 (MPN) 共同发生,质疑了潜在的原因.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 罕见疾病 罕见疾病
背景情况:
- 系统毛细血管泄漏综合征 (SCLS) 是一种罕见的疾病,其特点是血管透性增加的反复发作.
- 矛盾的是,SCLS与血和低albuminemia一起呈现和低血.
- 精确的SCLS病理生理学仍然在很大程度上是未知的.
研究的目的:
- 报告一种与骨髓增殖性瘤 (MPN) 共存的异常性SCLS的独特病例.
- 探索SCLS,MPN和之前的COVID-19感染之间的潜在关系.
- 调查SCLS的病因触发因素,特别是在并发MPN的背景下.
主要方法:
- 一个38岁的男性患者的病例报告.
- 对临床表现,诊断结果和病史的审查,包括COVID-19感染和免疫.
- 对SCLS和骨髓扩散性瘤的诊断工作.
主要成果:
- 这位患者呈现出异常性SCLS.
- 同时诊断出骨髓增殖性新生瘤 (MPN).
- 该患者有COVID-19感染史和之前的免疫接种.
结论:
- 这是第一次报告SCLS与MPN共存的病例.
- 这起案件引发了关于病毒感染 (COVID-19),免疫,MPN和SCLS发展之间的相互作用的问题.
- 需要进一步的研究来阐明SCLS的触发机制,特别是在患有血液性恶性瘤的患者中.
相关概念视频
Pleural Effusion I: Introduction
448
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
448
Acute Respiratory Failure-III
153
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
153
Pleural Effusion II: Symptoms and Management
151
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
151
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K


